Home / Market News / $CTVA

$CTVA news and market catalysts

The 34 most recent market catalysts affecting $CTVA, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

34 catalysts 6 high impact 11 bullish 15 bearish Agriculture
Nov 16, 2026 Corporate Catalyst Bearish Impact 65
Mizuho Lowers Corteva Price Target to $13
Mizuho has lowered its price target for Corteva, Inc. to $13. This action stems from reported operational and financial headwinds the company is facing in Brazil, which have negati…
Nov 16, 2026 Corporate Catalyst Bearish Impact 55
KeyBanc Adjusts Corteva Price Target
KeyBanc analyst Salvator Tiano has updated his outlook on Corteva, Inc., reducing the price target from $17 to $14. Despite the price target cut, the analyst maintained a bullish r…
Nov 13, 2026 Corporate Catalyst Bearish Impact 95
Levi & Korsinsky Investigates Corteva, Inc. Following Stock Decline
Corteva's stock plummeted by 24.30% after the company revised its full-year 2026 outlook downwards, citing challenging market conditions in Brazil. This significant guidance cut ha…
Nov 13, 2026 Corporate Catalyst Bearish Impact 55
Oppenheimer Downgrades Corteva to Market Perform
Oppenheimer has downgraded Corteva, Inc. from Outperform to Market Perform, indicating a more cautious stance on the company's stock. This matters because analyst ratings can influ…
Nov 13, 2026 Corporate Catalyst Bearish Impact 65
RBC Capital Markets Cuts Price Target on Corteva
RBC Capital Markets cut its price target on Corteva (CTVA) shares from $17 to $11, a substantial reduction of over 35%. This action signals a significant downward revision in RBC's…
Nov 11, 2026 Corporate Catalyst Bearish Impact 92
Corteva Reports Third-Quarter 2026 Results and Updates Full-Year Outlook
Corteva's Q3 2026 results show a significant 9% decline in net sales and a GAAP loss, which is a direct negative catalyst for the company. The primary drivers are identified as pri…
Nov 9, 2026 Corporate Catalyst Bearish Impact 65
Lawsuit Filed Against Corteva and The Dow Chemical Company Over Chlorpyrifos
A new lawsuit has been filed against Corteva, Inc., Corteva Agriscience LLC, and The Dow Chemical Company in Los Angeles County Superior Court. The plaintiffs allege that chlorpyri…
Oct 23, 2026 Corporate Catalyst Bearish Impact 75
Corteva Trims Quarterly Dividend to $0.05 per Share
Corteva, Inc. has announced a substantial reduction in its quarterly dividend, from $0.18 to $0.05 per share. This decision indicates a change in the company's capital allocation s…
Oct 12, 2026 Corporate Catalyst Neutral Impact 65
Corteva Says PFAS Litigation-Related Court Order Doesn't Affect Completion Of Vylor Separation And Is Not In Effect Pending Resolution Of The Motion
Corteva is embroiled in litigation from multiple states and a sovereign entity over its separation from Vylor, specifically concerning PFAS. A temporary restraining order was issue…
Oct 7, 2026 Corporate Catalyst Neutral Impact 85
Corteva Completes Vylor Spin-Off: CTVA Vs. VYLR — Which Stock Is The Better Play Now?
Corteva Inc. completed the spin-off of its seed operating segment into Vylor Inc. on October 1, 2026. This created two distinct entities: Corteva (CTVA) as a pure-play crop protect…
Oct 7, 2026 Corporate Catalyst Bullish Impact 65
Keybanc Upgrades Corteva to Overweight, Announces $17 Price Target
Keybanc analyst Salvator Tiano upgraded Corteva's stock rating from 'Sector Weight' to 'Overweight' and announced a new price target of $17. This action signals increased confidenc…
Oct 6, 2026 Corporate Catalyst Bullish Impact 75
Corteva shares are trading higher after JP Morgan upgraded the stock from Neutral to Overweight.
The upgrade of Corteva (CTVA) by JP Morgan from Neutral to Overweight is a significant positive catalyst for the stock. Analyst upgrades from major investment banks often lead to i…
Oct 2, 2026 Corporate Catalyst Neutral Impact 85
How Does Corteva, Vylor Stand After Spin-off?
Corteva completed the spin-off of its seed and genetics business into Vylor, creating two distinct agricultural companies. This filing provides crucial standalone financial guidanc…
Oct 1, 2026 Corporate Catalyst Bearish Impact 85
Corteva shares are trading lower after the company completed the spin-off of its advanced seed and genetics business Vylor.
The spin-off of Vylor from Corteva is a significant corporate action that alters the parent company's financial structure and strategic focus. The immediate negative reaction in Co…
Oct 1, 2026 Corporate Catalyst Bearish Impact 95
Why Is Corteva Stock Sinking Thursday?
Corteva Inc. completed the long-anticipated spin-off of its seed and genetics business, now operating as Vylor Inc. This corporate action led to an 82% drop in Corteva's stock pric…
Oct 1, 2026 Corporate Catalyst Bullish Impact 75
Corteva Completes Spin Off Of Its Advanced Seed And Genetics Business
Corteva, Inc. has completed the spin-off of its advanced seed and genetics business, a move that was previously announced and anticipated. This filing confirms the execution of tha…
Sep 18, 2026 Corporate Catalyst Neutral Impact 55
Argus Research Reiterates Buy on Corteva, Maintains $91 Price Target
Argus Research analyst Alexandra Yates reiterated a 'Buy' rating for Corteva (CTVA) and maintained her $91 price target. This action signals continued analyst confidence in the com…
Sep 16, 2026 Corporate Catalyst Bearish Impact 55
BMO Capital Maintains Outperform on Corteva, Lowers Price Target to $95
BMO Capital analyst Joel Jackson maintained an 'Outperform' rating on Corteva (CTVA) but lowered the price target from $100 to $95. This action signals that while the analyst still…
Sep 16, 2026 Corporate Catalyst Bearish Impact 55
RBC Capital Reiterates Outperform on Corteva, Maintains $103 Price Target
RBC Capital analyst Arun Viswanathan reiterated an 'Outperform' rating and maintained a $103 price target for Corteva. This action signals continued confidence from a major financi…
Sep 15, 2026 Corporate Catalyst Neutral Impact 75
Corteva Sees FY2029 Sales $8.400B-$8.700B
Corteva's 8-K filing discloses its sales outlook for fiscal year 2029, projecting revenues in the range of $8.4 billion to $8.7 billion. This guidance is significant as it provides…
Sep 15, 2026 Corporate Catalyst Bullish Impact 65
Corteva Sees $300M Of Gross Productivity Benefits Across 2027-2029; Corteva Sees More Than $200M Of Net Cost Improvement Across 2027-2029, After Inflation And Tariff Offsets; Residual Inflation And Tariff Impacts Will Be Concentrated Mostly In 2027; Says Its Seed-Treatment Portfolio Is Now About $500M, Vs. About $400M Before Separation
Corteva's 8-K filing is a disclosure related to its Investor Day, where the company provided forward-looking statements regarding its operational efficiency and product portfolio. …
Sep 15, 2026 Corporate Catalyst Neutral Impact 75
Reported Earlier, Corteva Rejects State Attorneys General Allegations, Vows To Vigorously Defend Planned Corporate Separation
This headline signals a significant corporate catalyst for Corteva (CTVA) as it faces legal challenges to its planned corporate separation. The 'vigorous defense' implies potential…
Sep 9, 2026 Corporate Catalyst Bullish Impact 75
Corteva Announces Definitive Agreement To Form 50/50 Crop Protection Joint Venture With Globachem; Expects Close In Q4 2026
This joint venture represents a significant strategic move for Corteva, aiming to leverage Globachem's strengths for expanded market access and a broader product portfolio in crop …
Aug 18, 2026 Corporate Catalyst Bearish Impact 55
UBS Maintains Neutral on Corteva, Lowers Price Target to $85
UBS analyst Joshua Spector has adjusted Corteva's price target downwards from $89 to $85, while keeping a 'Neutral' rating. This action suggests a revised valuation perspective fro…
Aug 3, 2026 Corporate Catalyst Bullish Impact 55
BMO Capital Maintains Outperform on Corteva, Raises Price Target to $100
BMO Capital analyst Joel Jackson maintained an 'Outperform' rating on Corteva and raised the price target from $95 to $100. This action signals continued confidence from a prominen…
Jul 31, 2026 Corporate Catalyst Bearish Impact 75
Corteva shares are trading lower after the company reported mixed Q2 financial results and raised its FY26 adjusted EPS guidance with its midpoint below estimates.
This headline indicates a significant corporate catalyst for Corteva. While raising long-term guidance might seem positive, the market is focusing on the immediate disappointment o…
Jul 30, 2026 Corporate Catalyst Bearish Impact 75
Corteva shares are trading lower after the company reported mixed Q2 financial results
The headline directly points to Corteva's Q2 financial results as the catalyst for its stock decline. 'Mixed' results often imply that while some metrics might have met or exceeded…
Jul 30, 2026 Corporate Catalyst Bullish Impact 75
Corteva Raises FY2026 Adj EPS Guidance from $3.45-$3.70 to $3.60-$3.80 vs $3.75 Est
Corteva (CTVA) announced an upward revision to its adjusted EPS guidance for fiscal year 2026, moving the range from $3.45-$3.70 to $3.60-$3.80. This update is significant as it in…
Jul 30, 2026 Corporate Catalyst Neutral Impact 75
Corteva Q2 Adj. EPS $2.30 Beats $2.22 Estimate, Sales $6.379B Miss $6.582B Estimate
Corteva's Q2 results are a significant corporate catalyst for the agricultural sector. The EPS beat suggests strong operational efficiency or favorable pricing, which could be a po…
Jul 28, 2026 Corporate Catalyst Neutral Impact 75
Watching Corteva; Hearing Zacks Surprise Trader Buys Stock
The headline indicates that Zacks Surprise Trader, a service known for identifying stocks with high earnings surprise potential, has bought Corteva stock. This is a significant sho…
Jul 23, 2026 Corporate Catalyst Bullish Impact 55
Oppenheimer Maintains Outperform on Corteva, Raises Price Target to $95
Oppenheimer analyst Kristen Owen has maintained an 'Outperform' rating on Corteva (CTVA) and raised the price target from $89 to $95. This indicates a positive outlook from a promi…
Jul 21, 2026 Corporate Catalyst Bullish Impact 55
RBC Capital Maintains Outperform on Corteva, Raises Price Target to $103
RBC Capital's analyst Arun Viswanathan maintained an 'Outperform' rating for Corteva (CTVA) and raised the price target from $97 to $103. This action signals continued analyst conf…
Jul 20, 2026 Corporate Catalyst Bullish Impact 55
B of A Securities Maintains Buy on Corteva, Raises Price Target to $96
B of A Securities analyst Steve Byrne maintained a 'Buy' rating on Corteva and raised the price target from $90 to $96. This action indicates an analyst's increased confidence in C…
Jul 14, 2026 Market Technicals Bullish Impact 55
Mizuho Maintains Outperform on Corteva, Raises Price Target to $97
Mizuho analyst John Roberts maintained an 'Outperform' rating on Corteva (CTVA) and raised the price target by $1 to $97. This action signals continued confidence from a prominent …
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.